Market capitalization | €12.74b |
Enterprise Value | €17.80b |
P/E (TTM) P/E ratio | 152.42 |
EV/FCF (TTM) EV/FCF | 63.43 |
EV/Sales (TTM) EV/Sales | 5.36 |
P/S ratio (TTM) P/S ratio | 3.83 |
P/B ratio (TTM) P/B ratio | 4.78 |
Dividend yield | 0.40% |
Last dividend (FY23) | €0.73 |
As a Free StocksGuide user, you can view scores for all 6,891 stocks worldwide.
5 Analysts have issued a Sartorius forecast:
5 Analysts have issued a Sartorius forecast:
Sep '24 |
+/-
%
|
||
Revenue | 3,324 3,324 |
8%
8%
|
|
Gross Profit | 1,461 1,461 |
19%
19%
|
|
EBITDA | 872 872 |
32%
32%
|
EBIT (Operating Income) EBIT | 486 486 |
48%
48%
|
Net Profit | 83 83 |
76%
76%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sartorius AG is an international laboratory and process technology provider for the biotech, pharmaceutical, and food industries. It operates through the Bioprocess Solutions and Lab Products and Services divisions. The Bioprocess Solutions division focuses on the major areas of activity of filtration, fluid management, fermentation, and purification. The Lab Products and Services division focuses on lab balances, pipettes, and laboratory water purification systems. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
Head office | Germany |
CEO | Joachim Kreuzburg |
Employees | 14,614 |
Founded | 1870 |
Website | www.sartorius.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.